News
2019
-
Holdings
Investors
October 30, 2019
-
Reference Data
-
Holdings
Investors
October 30, 2019
-
Financial Statements for the 2nd Quarter of Fiscal 2019
-
Group Company
R&D
October 1, 2019
-
Taisho and Moberg Pharma sign exclusive license agreement for the development and commercialization of MOB-015 in Japan
-
Holdings
Corporate
July 30, 2019
-
Notice Concerning Determination of Details of Stock Options (Stock Acquisition Rights)
-
Holdings
Investors
July 29, 2019
-
Reference Data
-
Holdings
Investors
July 29, 2019
-
Financial Statements for the 1st Quarter of Fiscal 2019
-
Holdings
Investors
July 29, 2019
-
Notice of Revision of Half-Year and Full-Year Forecasts for the Fiscal Year Ending March 31, 2020
-
Holdings
Corporate
July 2, 2019
-
Taisho Completed Procedures for the Acquisition of UPSA SAS
-
Holdings
Corporate
June 27, 2019
-
Notice Concerning Issuance of Stock Options (Stock Acquisition Rights)
-
Holdings
Corporate
May 20, 2019
-
Duoc Hau Giang Pharmaceutical JSC became a consolidated subsidiary of Taisho
-
Holdings
Investors
May 13, 2019
-
Reference Data
-
Holdings
Investors
May 13, 2019
-
Financial Statements for Fiscal 2018
-
Holdings
Investors
May 13, 2019
-
Notice Regarding Dividends from Surplus
-
Holdings
Investors
May 13, 2019
-
Notice of Retirement of Treasury Stock
-
Holdings
Corporate
April 18, 2019
-
Notice Regarding the Result of the Tender Offer for Shares of Duoc Hau Giang Pharmaceutical JSC
-
Holdings
Corporate
February 28, 2019
-
Notice Regarding the Tender Offer for Shares of Duoc Hau Giang Pharmaceutical JSC
-
Holdings
Investors
January 30, 2019
-
Reference Data
-
Holdings
Investors
January 30, 2019
-
Financial Statements for the 3rd Quarter of Fiscal 2018
-
Holdings
Corporate
January 30, 2019
-
Notice of Change in a Sub-subsidiary